Roth Capital Brokers Increase Earnings Estimates for ZVRA
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital boosted their Q2 2025 earnings estimates for Zevra Therapeutics in a research note issued to investors on Tuesday, May 13th. Roth Capital analyst J. Aschoff now expects that the company will post earnings of $2.12 per share for the quarter, up […]
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Free Report) – Equities research analysts at Roth Capital boosted their Q2 2025 earnings estimates for Zevra Therapeutics in a research note issued to investors on Tuesday, May 13th. Roth Capital analyst J. Aschoff now expects that the company will post earnings of $2.12 per share for the quarter, up […]
